Despite significant gains in gender equity over the last few decades, a bias still reigns in one area of medicine, writes Prof Peter Rogers.
He says the lack of female representation in both preclinical studies and clinical trials has put women at greater risk of adverse events from medical interventions.
But our Director of Research at the Women's writes in in The Conversation and Sydney Morning Herald that there is now light at the end of the tunnel.